Full Text View
Tabular View
No Study Results Posted
Related Studies
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
This study is ongoing, but not recruiting participants.
Study NCT01146535   Information provided by Amarillo Biosciences, Inc.

First Received on June 16, 2010.   Last Updated on August 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza A Virus Infection
Additional conditions recognized in this trial
Influenza, Human
Virus Diseases
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Interventions listed in this trial
Interferon-alpha
Oseltamivir
maltose
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferons
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Amarillo Biosciences, Inc.
CytoPharm, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services